• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.09% Nasdaq Down 0.07%

    VIVUS Inc. (VVUS)

    -NasdaqGS
    3.16 Down 0.01(0.28%) 9:35AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:3.17
    Open:N/A
    Bid:3.15 x 5000
    Ask:3.20 x 100
    1y Target Est:5.58
    Beta:2.34
    Earnings Date:Feb 23 - Feb 27 (Est.)
    Day's Range:3.15 - 3.17
    52wk Range:2.92 - 9.80
    Volume:18,670
    Avg Vol (3m):1,968,890
    Market Cap:327.73M
    P/E (ttm):N/A
    EPS (ttm):-0.72
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    VVUSDown 0.28%327.73M
    LLYDown 0.25%77.30B
    GSKDown 0.39%103.66B
    PFEUp 0.13%201.68B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):2.41
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.81
    Quarterly EPS Est (Dec-14) :-0.24
    Mean Recommendation*:3.5
    PEG Ratio (5 yr expected):-0.23

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    VIVUS, Inc., a biopharmaceutical company, develops and commercializes therapies to address unmet needs in obesity, sleep apnea, diabetes, and sexual health in the United States and the European Union. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback